Dianthus Therapeutics Banner

Event Details

Dianthus Therapeutics Announces Initiation of Phase 3 Emerge Trial of Claseprubart in Generalized Myasthenia Gravis
Press Release

43rd Annual J.P. Morgan Healthcare Conference

Jan 15, 2025 12:00 PM EST